Position in CRMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$487,123
+$146,741 QoQ
Shares Held
62,054
+23.8% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 194 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. CRMD ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in CRMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $487,123 | 62,054 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $340,382 | 50,130 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $494,809 | 42,546 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $456,768 | 39,275 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $395,570 | 32,108 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $164,385 | 26,686 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $189,904 | 23,445 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $148,793 | 18,415 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $69,630 | 16,081 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $62,052 | 14,635 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $45,394 | 12,073 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $44,670 | 12,073 | Shares | Defined | 2023-11-14 | |
| 2021-09-30 | $81,500 | 17,527 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $120,235 | 17,527 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $165,983 | 16,615 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||